Evelo Biosciences Inc (EVLO)
OTHER OTC:EVLO
US Market
Holding EVLO?
Track your performance easily

Evelo Biosciences (EVLO) Cash flow

214 Followers

Evelo Biosciences Cash Flow

EVLO's free cash flow for Q3 2023 was $-10.46M. For the 2023 fiscal year, EVLO's free cash flow was decreased by $-3.65M and operating cash flow was $-10.41M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -73.70M$ -101.23M$ -96.72M$ -73.06M$ -71.98M$ -47.27M
Investing Cash Flow
$ 273.00K$ -622.00K$ -1.48M$ -1.31M$ 51.97M$ -60.13M
Financing Cash Flow
$ 20.76M$ 81.66M$ 97.54M$ 65.47M$ 4.99M$ 162.01M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 104.57M$ 49.10M$ 69.75M$ 70.42M$ 79.34M$ 94.36M
Income Tax Paid Supplemental Data
$ 49.00K$ 633.00K$ 25.00K$ 20.00K--
Interest Paid Supplemental Data
$ 5.18M$ 4.22M$ 3.38M$ 2.17M$ 1.17M$ 742.00K
Issuance Of Capital Stock
$ 29.17M$ 84.54M$ 81.75M$ 54.99M-$ 75.83M
Issuance Of Debt
$ -8.17M$ -3.12M$ 14.78M$ 10.00M$ 4.48M$ 4.97M
Repayment Of Debt
$ -52.66M$ -47.61M--$ -15.00M-
Free Cash Flow
$ -73.99M$ -101.86M$ -98.21M$ -74.38M$ -75.01M$ -52.56M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Evelo Biosciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis